Clinical Nutrition Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)

The Clinical Nutrition Market is segmented by Route of Administration (Oral and Enteral, and Parenteral), Application (Nutritional Support in Malnutrition, Nutritional Support in Metabolic Disorders, Nutritional Support in Gastrointestinal Diseases, Nutritional Support in Neurological Diseases, Nutritional Support in Cancer and Nutritional Support in Other Diseases), End User (Pediatric and Adult), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Clinical Nutrition Market Overview
Study Period:

2018-2026

Base Year:

2020

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

6.04 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Clinical Nutrition Market is estimated to be valued at USD 51,775.3 million in 2020 and USD 73610.31 million in 2026, registering a 6.04 % CAGR during the forecast period.

COVID-19 infection has become a major public health concern and clinical nutrition is playing a crucial role concerning the prevention of the infection, treatment of infection-associated malnutrition, and possibly the infection itself. For instance, the European Society for Clinical Nutrition and Metabolism has issued guidelines related to nutritional management in ICU patients infected with COVID-19. Thus, a positive impact can be expected on the market studied due to COVID-19.

Certain factors are propelling the clinical nutrition growth of the market that includes the increasing prevalence of metabolic disorders, high spending on healthcare, and the rise of the middle class in the emerging economies. Over the past decade, the prevalence of metabolic disorders has increased. According to the study of Global Coalition on Aging, November 2020, the prevalence of malnutrition in the patient hospitalized was around 31%. According to the Global Surgery Foundation, nearly 30% of worldwide diseases can be treated with surgery and require the direct care of a surgeon. Clinical nutrition plays a major part during surgeries to minimize any adverse consequences to patients and enable the surgeons to work in a controlled environment. Thus, with the rising burden of diseases and the volume of surgeries, the clinical nutrition market is expected to boost during the forecast period.

Furthermore, as per the World Ageing Population report, in 2020, about 727 million people worldwide are aged 65 years and above. This number is further expected to reach 1.5 billion by the year 2050. Elderly population is often susceptible to acquiring chronic diseases, leading to surgeries. In July 2020, Goodmills Innovation introduced ''Spermidino EVO'' , wheat germ concentrate which is specifically developed for immunity boosting in ageing population. Hence, with the growing number of elderly population and development of clinical nutrition products specific to ageing population is expected to thrive the market growth.

Scope of the Report

Clinical malnutrition refers to the condition that can be treated with clinical intervention, through the use of specialized nutrients that are considered as proper medications, rather than as supplements. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement in the metabolic system of the body by providing adequate supplements, such as minerals, vitamins, and other supplements. Additionally, a higher number of premature births also demand advanced clinical nutrition. The Clinical Nutrition Market is segmented by Route of Administration (Oral and Enteral, and Parenteral), Application (Nutritional Support in Malnutrition, Nutritional Support in Metabolic Disorders, Nutritional Support in Gastrointestinal Diseases, Nutritional Support in Neurological Diseases, Nutritional Support in Cancer and Nutritional Support in Other Diseases), End-User (Pediatric and Adult), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The report offers the value (in USD million) for the above segments.

By Route of Administration
Oral and Enteral
Parenteral
By Application
Nutritional Support for Malnutrition
Nutritional Support for Metabolic Disorders
Nutritional Support for Gastrointestinal Diseases
Nutritional Support for Cancer
Nutritional Support in Neurological Diseases​
Nutritional Support in Other Diseases
By End User
Pediatric
Adult
Geography
North America
United States (By Route of Administration, By Application, and By End User)
Canada (By Route of Administration, By Application, and By End User)
Mexico (By Route of Administration, By Application, and By End User)
Europe
Germany (By Route of Administration, By Application, and By End User)
United Kingdom (By Route of Administration, By Application, and By End User)
France (By Route of Administration, By Application, and By End User)
Italy (By Route of Administration, By Application, and By End User)
Spain (By Route of Administration, By Application, and By End User)
Rest of Europe (By Route of Administration, By Application, and By End User)
Asia-Pacific
China (By Route of Administration, By Application, and By End User)
Japan (By Route of Administration, By Application, and By End User)
India (By Route of Administration, By Application, and By End User)
Australia (By Route of Administration, By Application, and By End User)
South Korea (By Route of Administration, By Application, and By End User)
Rest of Asia-Pacific (By Route of Administration, By Application, and By End User)
Middle East and Africa
GCC (By Route of Administration, By Application, and By End User)
South Africa (By Route of Administration, By Application, and By End User)
Rest of Middle East and Africa (By Route of Administration, By Application, and By End User)
South America
Brazil (By Route of Administration, By Application, and By End User)
Argentina (By Route of Administration, By Application, and By End User)
Rest of South America (By Route of Administration, By Application, and By End User)

Report scope can be customized per your requirements. Click here.

Key Market Trends

Nutritional Support for Metabolic Disorders is Expected to have the Fastest Growth in the Route of Administration Segment

People suffering from metabolic disorders such as diabetes are at high risk of acquiring COVID-19 infection. According to the International Diabetes Federation, 2020, people with pre-existing medical conditions such as diabetes, obesity are more prone to be infected with the SARS-CoV-2 virus, due to compromised immune systems in these individuals. Additionally, treating diabetic patients infected with COVID-19 would turn out to be difficult as the virus tends to grow immensely in elevated blood sugar levels. Controlling the blood sugar levels is of utmost importance in treating COVID-19 infected patients, and thus, nutritional support plays a vital role in this context, thereby aiding in the growth of the segment. 

Furthermore, the rising burden of metabolic disorders is also increasing the demand for clinical nutrition. According to International Diabetes Federation 2019, about over 425 million people are living with diabetes and this number is expected to reach 700 million in the year 2045. Hence, the growing burden of metabolic disorder along with the introduction of new products the market is expected to fuel in this segment. Also, the growing product launches are expected to propel market growth. For instance, As a result, in February 2020, Galen has launched an innovative medical food PKU EASY Microtabs, for people living with the rare, inherited metabolic disorder, phenylketonuria (PKU). Thus, owing to the above-mentioned factors, the studied segment is expected to witness significant growth in the coming years.

Clinical Nutrition Market Share

To understand key trends, Download Sample Report

North America holds the Majority Share in the Clinical Nutrition Market and is Expected to Follow the Same Trend over the Forecast Period

North America contributes heavily to the market growth, in comparison to the other regions, in the forecast period. The emergence of COVID-19 has led to the shortages of clinical nutritional products in this region. As per the data provided by the American Society for Parenteral and Enteral Nutrition (ASPEN) as of January 2021, certain parenteral products including Multi-Vitamin Infusion (Adult and Pediatric), Amino Acids, Potassium Acetate Injection, USP, Sodium Acetate Injection, USP, and Sodium Chloride 23.4% Injection are currently at a shortage.

In order to meet the evolving demands driven by new consumer buying behavior in the midst of the COVID-19 pandemic, manufacturers have increased production, and are working with retailers and government agencies to help ensure adequate availability of and continued access to oral clinical nutrition products.

Furthermore, some of the primary factors attributing to the growth of the clinical nutrition market include an increase in the prevalence of metabolic disorders and a rise in the geriatric population. According to the Centers for Disease Control and Prevention, the obesity rate among United States population was estimmated to be around 42.4% in 2017-2018. As per the statistics of the Center for Disease Control and Prevention, cancer and cardiovascular diseases are among the major burdens of the US healthcare sector. According to the data of the American Heart Association, in 2017, around 8,59,125 Americans died due to cardiovascular diseases. Hence, such instances indicates a rising demand for clinical nutrition products and thereby driving the market growth.

Clinical Nutrition

To understand geography trends, Download Sample Report

Competitive Landscape

The market players are continuously engaged in expanding their presence in the market through various inorganic growth strategies, such as acquisition, merger, strategic collaboration, and others, to gain significant market share and strengthen their product portfolios. In September 2019, Nestle SA launched an innovative drink “Boost Soothe” in the market. It is a clinical nutritional drink specially designed for cancer patients.​ Some of the key players in the market are Abbott Nutrition, Nestle Health Science, Baxter Healthcare, B. Braun Melsungen AG, Nutricia, BASF SE, and others.

Recent Developments

In September 2020, Baxter announced the approval of Clinimix and Clinimix E, with higher protein for patients requiring parenteral nutrition.

In April 2020, AYMES International introduced a vegan oral clinical nutrition under the product name “AYMES ActaSolve Smoothie” for dietary management and those who are suffering from or are at the risk of malnutrition.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Metabolic Disorders

      2. 4.2.2 High Spending on Healthcare

      3. 4.2.3 Growing Geriatric Population

    3. 4.3 Market Restraints

      1. 4.3.1 Imprecise Perception about Clinical Nutrition

      2. 4.3.2 Reduction in Birth Rates

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Route of Administration

      1. 5.1.1 Oral and Enteral

      2. 5.1.2 Parenteral

    2. 5.2 By Application

      1. 5.2.1 Nutritional Support for Malnutrition

      2. 5.2.2 Nutritional Support for Metabolic Disorders

      3. 5.2.3 Nutritional Support for Gastrointestinal Diseases

      4. 5.2.4 Nutritional Support for Cancer

      5. 5.2.5 Nutritional Support in Neurological Diseases​

      6. 5.2.6 Nutritional Support in Other Diseases

    3. 5.3 By End User

      1. 5.3.1 Pediatric

      2. 5.3.2 Adult

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States (By Route of Administration, By Application, and By End User)

        2. 5.4.1.2 Canada (By Route of Administration, By Application, and By End User)

        3. 5.4.1.3 Mexico (By Route of Administration, By Application, and By End User)

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany (By Route of Administration, By Application, and By End User)

        2. 5.4.2.2 United Kingdom (By Route of Administration, By Application, and By End User)

        3. 5.4.2.3 France (By Route of Administration, By Application, and By End User)

        4. 5.4.2.4 Italy (By Route of Administration, By Application, and By End User)

        5. 5.4.2.5 Spain (By Route of Administration, By Application, and By End User)

        6. 5.4.2.6 Rest of Europe (By Route of Administration, By Application, and By End User)

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China (By Route of Administration, By Application, and By End User)

        2. 5.4.3.2 Japan (By Route of Administration, By Application, and By End User)

        3. 5.4.3.3 India (By Route of Administration, By Application, and By End User)

        4. 5.4.3.4 Australia (By Route of Administration, By Application, and By End User)

        5. 5.4.3.5 South Korea (By Route of Administration, By Application, and By End User)

        6. 5.4.3.6 Rest of Asia-Pacific (By Route of Administration, By Application, and By End User)

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC (By Route of Administration, By Application, and By End User)

        2. 5.4.4.2 South Africa (By Route of Administration, By Application, and By End User)

        3. 5.4.4.3 Rest of Middle East and Africa (By Route of Administration, By Application, and By End User)

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil (By Route of Administration, By Application, and By End User)

        2. 5.4.5.2 Argentina (By Route of Administration, By Application, and By End User)

        3. 5.4.5.3 Rest of South America (By Route of Administration, By Application, and By End User)

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories (Abbott Nutrition)

      2. 6.1.2 Nestle Health Science

      3. 6.1.3 Baxter Healthcare

      4. 6.1.4 B. Braun Melsungen AG

      5. 6.1.5 Nutricia

      6. 6.1.6 BASF SE

      7. 6.1.7 Perrigo Company PLC

      8. 6.1.8 Fresenius Kabi

      9. 6.1.9 Danone

      10. 6.1.10 AYMES International Ltd.

      11. 6.1.11 Reckitt Benckiser

      12. 6.1.12 Medifood International Ltd.

      13. 6.1.13 Nualtra Ltd.

      14. 6.1.14 Meditrition Inc.

      15. 6.1.15 Victus Inc.

      16. 6.1.16 Medihub

      17. 6.1.17 SternLife GmbH & Co. KG

      18. 6.1.18 Nutra Supplements

      19. 6.1.19 SGD Pharma

      20. 6.1.20 Nutrinovo

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Clinical Nutrition Market market is studied from 2018 - 2026.

The Global Clinical Nutrition Market is growing at a CAGR of 6.04% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

  • Abbott Nutrition
  • Nestle Health Science
  • Baxter Healthcare
  • B. Braun Melsungen AG
  • Danone

Are the major companies operating in Global Clinical Nutrition Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!